Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Endocrinology
Pituitary adenoma
Pituitary adenoma
A pituitary adenoma is a benign tumour of the pituitary gland. They are common (10% of all people) but in most cases will never be found (asymptomatic) or are found as an incidental findings. They account for around 10% of adult brain tumours.Pituitary adenomas can be classified according to:
- size (a microadenoma is <1cm and a macroadenoma is ≥1cm)
- hormonal status (a secretory/functioning adenoma produces an excess of a particular hormone and a non-secretory/functioning adenoma does not produce a hormone to excess)
Prolactinomas are the most common type and they produce an excess of prolactin. After prolactinomas, non-secreting adenomas are the next most common, then GH-secreting and then ACTH-secreting adenomas.
Pituitary adenomas typically cause symptoms by:
- excess of a hormone (e.g. Cushing's disease due to excess ACTH, acromegaly due to excess GH or amenorrhea and galactorrhea due to excess prolactin)
- depletion of a hormone(s) (due to compression of the normal functioning pituitary gland)
- non-functioning tumours, therefore, present with generalised hypopituitarism
- stretching of the dura within/around the pituitary fossa (causing headaches)
- compression of the optic chiasm (causing a bitemporal hemianopia due to crossing nasal fibers)
Alternatively, pituitary adenomas, particularly microadenomas, can be an incidental finding on neuroimaging and therefore called a 'pituitary incidentaloma'.
Investigation requires:
- a pituitary blood profile (including GH, prolactin, ACTH, FSH, LSH and TFTs)
- formal visual field testing
- MRI brain with contrast
Differential diagnoses include:
- pituitary hyperplasia
- craniopharyngioma
- meningioma
- brain metastases
- lymphoma
- hypophysitis
- vascular malformation (e.g. aneurysm)
Treatment may include a combination of
- medical therapy:
- prolactinomas are generally treated first-line with dopamine agonists (e.g., cabergoline or bromocriptine).
- somatostatin analogues (e.g., octreotide, lanreotide) and GH receptor antagonists (e.g., pegvisomant) are used for GH-secreting adenomas
- for ACTH-secreting adenomas, medical therapy may include cortisol synthesis inhibitors (e.g., ketoconazole, metyrapone) and neuromodulators like pasireotide
- transsphenoidal surgery
- the primary treatment for most pituitary adenomas is transsphenoidal surgery, especially for non-functioning and ACTH- or GH-secreting adenomas
- surgical intervention aims to remove the tumour mass, normalise hormone levels, and
- non-functioning adenomas are generally diagnosed due to their compressive symptoms (e.g. visual problems) or hormone deficiencies - surgery is therefore the first-line treatment
- radiotherapy
- indicated for residual or recurrent tumours post-surgery
+PassMedicine Notes
A pituitary adenoma is a benign tumour of the pituitary gland. They are common (10% of all people) but in most cases will never be found (asymptomatic) or are found as an incidental findings. They account for around 10% of adult brain tumours.
Pituitary adenomas can be classified according to:- size (a microadenoma is